BMI

BMI is a for-profit corporate entity that specializes in providing medical laboratory equipment, reagents, and supplies to the U.S. Department of Defense, particularly the Defense Health Agency and Army Medical Command. The company has been registered to receive federal contract awards since November 2008. BMI primarily supplies reagents, analyzers, and consumables for hematology and pathology testing equipment used in military medical facilities, with a focus on supporting operations in South Korea.

Through its federal contract awards, BMI has consistently delivered a range of medical supplies to support laboratory operations at overseas military facilities. The company has provided reagents for Beckman Coulter hematology analyzers, IRICell3000 systems, and various pathology supplies including auxiliary reagents, hemostasis analyzers, screening tests, disposables, and accessories. These supplies have been primarily delivered to the Brian D. Allgood Army Hospital and other medical facilities in South Korea. BMI has received multiple delivery orders from the Defense Health Agency and Army Medical Command, with individual order values ranging from approximately $28,000 to $303,000. The company has also supplied isolation and surgical gowns during the COVID-19 pandemic. Notably, BMI's contract awards have not utilized any set-aside designations, indicating that it competes for these contracts in the open market.

BMI holds a significant indefinite delivery contract (IDC) with the Department of Defense, specifically the Defense Health Agency. This single-award IDC, valued at $2,937,284.04, was awarded on July 1, 2020, and runs through September 30, 2024. The contract focuses on providing reagents for the IRICell3000 system to support medical operations in South Korea. Under this IDC, the Defense Health Agency and Army Medical Command have issued multiple firm fixed-price delivery orders to BMI, with values ranging from $28,000 to $91,000. These orders call for the delivery of reagents to locations in South Korea from October 2020 through September 2023, supporting ongoing medical testing, research, and health initiatives for military and civilian personnel. This IDC demonstrates BMI's important role in maintaining critical medical supply chains for U.S. military operations in South Korea.